Federal Register / Vol. 72, No. 13 / Monday, January 22, 2007 / Notices 2707 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4218, 

MSC 7812, Bethesda, MD 20892, (301) 435–

2778, wangjia@csr.nih.gov. 

Name of Committee: Immunology 

Integrated Review Group, Cellular and 

Molecular Immunology—B Study Section. 

Date: February 15–16, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Betty Hayden, PhD, 

Scientific ReviewAdministrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4206, 

MSC 7812, Bethesda, MD 20892, 301–435–

1223, haydenb@csr.nih.gov. 

Name of Committee: Health of the 

Population Integrated Review Group, Kidney, 

Nutrition, Obesity and Diabetes Study 

Section. 

Date: February 15–16, 2007. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Christopher T. Sempos, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3146 

MSC 7770, Bethesda, MD 20892, (301) 451–

1329, semposch@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, BTSS 

Member Conflict ZRG1 SBIB–E (03) M. 

Date: February 15, 2007. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Roberto J. Matus, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892, 301–435–

2204, matusr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SRA 

Conflict-Cardiovascular Differentiation and 

Development. 

Date: February 16, 2007. 

Time: 10 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Wyndham Washington, DC, 1400 M 

Street, NW., Washington, DC 20005. 

Contact Person: Lawrence E. Boerboom, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5156, 

MSC 7814, Bethesda, MD 20892, (301) 435–

8367, boerboom@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Psychopathology, Developmental 

Disabilities and Disorders of Aging. 

Date: February 19, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Villa Florence Hotel, 225 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Dana Jeffrey Plude, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3176, 

MSC 7848, Bethesda, MD 20892, 301–435–

2309, pluded@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Oncology 

Area. 

Date: February 19, 2007. 

Time: 10 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Lambratu Rahman, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, 301–451–

3493, rahmanl@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group, 

Bacterial Pathogenesis Study Section. 

Date: February 20–21, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue, NW., Washington, DC 20037. 

Contact Person: Richard G. Kostriken, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7808, Bethesda, MD 20892, 301–402–

4454, kostrikr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cancer 

Diagnostic and Treatment II, SBIR/STTR. 

Date: February 20–21, 2007. 

Time: 8 a.m. to 11:55 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Hungyi Shau, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, 301–435–

1720, shauhung@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cancer 

Diagnostic and Treatment I, SBIR/STTR. 

Date: February 20–21, 2007. 

Time: 8 a.m. to 11:50 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Hungyi Shau, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, 301–435–

1720, shauhung@csr.nih.gov. 

Name of Committee: Cardiovascular 

Sciences Integrated Review Group, Vascular 

Cell and Molecular Biology Study Section. 

Date: February 20–21, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel and Executive 

Meeting Center, 8120 Wisconsin Avenue, 

Bethesda, MD 20814. 

Contact Person: Anshumali Chaudhari, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4124, 

MSC 7802, Bethesda, MD 20892, (301) 435–

1210, chaudhaa@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 12, 2007. 

David Clary, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–241 Filed 1–19–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Devices for Countercurrent 

Chromatography 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

404.7(a)(1)(i), that the National 

Institutes of Health (NIH), Department 

of Health and Human Services, is 

contemplating the grant of an exclusive 

worldwide license to practice the 

invention embodied in: HHS Ref. No. E–

274–1998 ‘‘Chromatographic Separation 

Apparatus and Method,’’ U.S. Patent 

No. 6,379,973; HHS Ref. No. E–044–

1993 ‘‘Variable-Position Cross-Axis 

Synchronous Coil Plant Centrifuge for 

Countercurrent Chromatography;’’ U.S. 

Patent 5,380,429; HHS Ref. No. E–148–

2001 ‘‘Method and Apparatus for 

Countercurrent Chromatography;’’ U.S. 

Patent Application No. 10/509,697 filed 

April 5, 2002; to CC Biotech LLC, a 

company incorporated under the laws of 

the State of Maryland having its 

headquarters in Rockville, Maryland. 

The United States of America is the 

assignee of the rights of the above 

inventions. The contemplated exclusive 

license may be granted in a field of use 

limited to instrumentation for 

countercurrent chromatographic 

purification of proteins and peptides. 

DATES: Only written comments and/or 

applications for a license received by 

the NIH Office of Technology Transfer 


rmajette on PROD1PC67 with NOTICES
2708 Federal Register / Vol. 72, No. 13 / Monday, January 22, 2007 / Notices 

on or before March 23, 2007 will be 

considered. 

ADDRESSES: Requests for a copy of the 

patent application, inquiries, comments 

and other materials relating to the 

contemplated license should be directed 

to: Michael A. Shmilovich, Esq., Office 

of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, MD 

20852–3804; Telephone: (301) 435–

5019; Facsimile: (301) 402–0220; E-mail: 

shmilovm@mail.nih.gov. A signed 

confidentiality nondisclosure agreement 

will be required to receive copies of any 

patent applications that have not been 

published by the United States Patent 

and Trademark Office or the World 

Intellectual Property Organization. 

SUPPLEMENTARY INFORMATION: The 

patents and patent applications 

intended for licensure disclose or cover 

the following: 

E–274–1998, ‘‘Chromatographic 

Separation Apparatus and Method,’’

U.S. Patent No. 6,379,973 

This invention pertains to an 

apparatus and method for separating 

bio-molecules using a salt (e.g., 

ammonium sulfate) gradient applied in 

a spiral flow channel divided by a 

dialysis membrane. The channels are 

compartmentalized into upper and 

lower rotary discs spinning anticlockwise to each other. Sample is 

introduced in a buffered solution into 

the lower channel flows in one direction 

while the salt flows in the other. The 

concentration of salt permeates the 

membrane and precipitates the large 

molecules on the other side. For 

example, proteins or polymers are 

precipitates sequentially in the channel 

and centrifugal forces the precipitate to 

the outer rim as it moves along the 

liquid stream. 

E–044–1993, ‘‘Variable-Position CrossAxis Synchronous Coil Planet 

Centrifuge for Countercurrent 

Chromatography,’’ U.S. Patent No. 

6,379,973 

This device is a cross-axis 

synchronous flow-through coil planet 

centrifuge which provides changeability 

in the position of the coils relative to the 

axis of rotation of the centrifuge. The 

advantage of this feature is to allow 

adjustment of the centrifugal force 

operating on the coils to accommodate 

different types of separations. The coils 

are arranged in columns which are 

mounted to column holders that in turn 

can be engaged to the rotary frame of the 

centrifuge in position in which the 

column holders intersect and do not 

intersect the rotary frame axis. This 

arrangement allows for larger coils 

which can hold between 200 ml and 800 

ml of sample. 

E–148–2001, ‘‘Method and Apparatus 

for Countercurrent Chromatography,’’

U.S. Patent Application No. 10/509,697 

(WIPO publication 03/087807) 

This device and method is an 

improvement of the countercurrent 

chromatography devices described 

above. This patent pending device is a 

new spiral design capable of holding 

heavier solvent systems suitable for 

peptides and proteins (e.g., for natural 

products). 

The prospective exclusive license will 

be royalty bearing and will comply with 

the terms and conditions of 35 U.S.C. 

209 and 37 CFR 404.7. The prospective 

exclusive license may be granted unless, 

within sixty (60) days from the date of 

this published notice, NIH receives 

written evidence and argument that 

establishes that the grant of the license 

would not be consistent with the 

requirements of 35 U.S.C. 209 and 37 

CFR 404.7. 

Properly filed competing applications 

for a license filed in response to this 

notice will be treated as objections to 

the contemplated license. Comments 

and objections submitted in response to 

this notice will not be made available 

for public inspection, and, to the extent 

permitted by law, will not be released 

under the Freedom of Information Act, 

5 U.S.C. 552. 

Dated: January 12, 2007. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. 07–253 Filed 1–19–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Citizenship and Immigration 

Services 

Agency Information Collection 

Activities: Extension of a Currently 

Approved Information Collection: 

Comment Request 

ACTION: 60-day notice of information 

collection under review; application for 

posthumous citizenship; form N–644. 

OMB control number 1615–0059. 

The Department of Homeland 

Security, U.S. Citizenship and 

Immigration Services has submitted the 

following information collection request 

for review and clearance in accordance 

with the Paperwork Reduction Act of 

1995. The information collection is 

published to obtain comments from the 

public and affected agencies. Comments 

are encouraged and will be accepted for 

sixty days until March 23, 2007. 

Written comments and suggestions 

regarding the item(s) contained in this 

notice, and especially regarding the 

estimated public burden and associated 

response time, should be directed to the 

Department of Homeland Security 

(DHS), USCIS, Director, Regulatory 

Management Division, Clearance 

Office,111 Massachusetts Avenue, NW., 

3rd Floor, Suite 3008, Washington, DC 

20529. Comments may also be 

submitted to DHS via facsimile to 202–

272–8352, or via e-mail at 

rfs.regs@dhs.gov. When submitting 

comments by e-mail add the OMB 

Control Number 1615–0059 in the 

subject box. 

Written comments and suggestions 

from the public and affected agencies 

concerning the collection of information 

should address one or more of the 

following four points: 

(1) Evaluate whether the collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information will have practical utility; 

(2) Evaluate the accuracy of the 

agency’s estimate of the burden of the 

collection of information, including the 

validity of the methodology and 

assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Extension of a currently approved 

information collection. 

(2) Title of the Form/Collection: 

Application for Posthumous 

Citizenship. 

(3) Agency form number, if any, and 

the applicable component of the 

Department of Homeland Security 

sponsoring the collection: Form N–644, 

U.S. Citizenship and Immigration 

Services. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Individual or 

households. The information collected 

will be used to determine an applicant’s 


rmajette on PROD1PC67 with NOTICES